Source: Virtual Congress 2020 – Investigations of COPD
Disease area: Airway diseases, Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
W. Chen (Basel, Switzerland), D. Schumann (Basel, Switzerland), M. Tamm (Basel, Switzerland), D. Stolz (Basel, Switzerland). Sputum rheology and bacteriology in stable and exacerbated chronic obstructive pulmonary disease. 3281

Member's Comments

No comment yet.

Related content which might interest you: Oropharyngeal and sputum microbiome dynamics with the same pattern following exacerbation of chronic obstructive pulmonary disease Source: International Congress 2018 – Studies on the mechanisms underlying airway disease Year: 2018 Acute reversibility of airflow limitation and sputum eosinophilia in chronic obstructive pulmonary disease Source: Eur Respir J 2004; 24: Suppl. 48, 579s Year: 2004 Microbiological screening infectious exacerbation of chronic obstructive pulmonary disease Source: Annual Congress 2012 - COPD treatment and varia Year: 2012 Relationship between proteases/anti-proteases system in induced sputum and spirometry testing in patients with chronic obstructive pulmonary disease Source: Eur Respir J 2006; 28: Suppl. 50, 634s Year: 2006 Profiling of sputum inflammatory mediators in asthma and chronic obstructive pulmonary disease Source: Annual Congress 2011 - Role of the biomarkers in airway diseases Year: 2011 Sputum microbiome richness is decreased in patients treated for acute exacerbations of eosinophilic chronic obstructive pulmonary disease Source: Virtual Congress 2020 – Burden and predictive factors for chronic lung diseases and comorbidity Year: 2020 Induced sputum cytology at different etiology of exacerbation of chronic obstructive bronchitis Source: Eur Respir J 2002; 20: Suppl. 38, 543s Year: 2002 Safety and effectiveness of sputum induction in chronic obstructive pulmonary disease Source: Eur Respir J 2001; 18: Suppl. 33, 67s Year: 2001 Measurements of sputum interleukin-5 in chronic obstructive pulmonary disease patients with eosinophilic airway inflammation Source: Annual Congress 2008 - Phenotyping of asthma and COPD Year: 2008 Value of serum and induced sputum surfactant protein-D in chronic obstructive pulmonary disease Source: Annual Congress 2011 - COPD: human studies Year: 2011 Chronic bronchitis sub-phenotype within COPD: inflammation in sputum and biopsies Source: Eur Respir J 2008; 31: 70-77 Year: 2008 Home hospitalisation of exacerbated chronic obstructive pulmonary disease patients Source: Eur Respir J 2003; 21: 58-67 Year: 2003 Systemic effects of chronic obstructive pulmonary disease Source: Eur Respir J 2003; 21: 347-360 Year: 2003 Peripheral lung remodelling in asthma and chronic obstructive pulmonary disease Source: Eur Respir J 2004; 24: 893-894 Year: 2004 Rhinovirus-infection in chronic obstructive pulmonary disease Source: Eur Respir J 2002; 20: Suppl. 38, 591s Year: 2002 Exacerbations of chronic obstructive pulmonary disease: when are bacteria important? Source: Eur Respir J 2002; 20: 9S-19S Year: 2002 Minimal bronchiectasis in chronic obstructive pulmonary disease Source: Annual Congress 2009 - Quality of life and symptoms in COPD Year: 2009 Pulmonary haemodynamic disorders in chronic obstructive pulmonary disease Source: International Congress 2019 – COPD treatment: cardiovascular, oxygen and vaccination studies Year: 2019 Systemic inflammation in chronic obstructive pulmonary disease Source: Eur Respir J 2003; 22: 5S-13S Year: 2003 Periodontitis and chronic obstructive pulmonary disease Source: Annual Congress 2006 - COPD and inflammation Year: 2006